RxDoctor Payments Data

Floyd Phillips, MD

Internal Medicine · Talbott, TNNPI 1942297916

Payments from drug & device makers

$12,330in general payments, 2019–2025

Across 899 payments — averaging $13.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • AstraZeneca$1K
  • Pfizer$767
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$662
  • Boehringer Ingelheim$547
  • plus $5K from 44 others

What the payments were for

  • Food & beverage$12,293100%
  • Education$380%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,330 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$53,275
Medicare patients
222
Services billed
859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide109$170,058
MounjaroTirzepatide143$158,835
JardianceEmpagliflozin110$121,883
EliquisApixaban75$77,190
XareltoRivaroxaban60$66,786
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$53,086
RexultiBrexpiprazole20$47,925
TrulicityDulaglutide29$41,041
Tresiba Flextouch U-200Insulin Degludec25$40,419
GlyxambiEmpagliflozin/Linagliptin23$31,844
FarxigaDapagliflozin Propanediol27$31,103
JanuviaSitagliptin Phosphate22$22,845
JanumetSitagliptin Phos/Metformin Hcl12$20,138
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$19,548
TrintellixVortioxetine Hydrobromide20$18,821

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$223$199,875172 claims
Novo NordiskOzempic$1,684$170,058109 claims
Boehringer IngelheimJardiance, Glyxambi$547$153,727133 claims
PfizerEliquis$767$77,19075 claims
Johnson & JohnsonXarelto, Invokamet$87$72,97971 claims
GSKTrelegy Ellipta, Anoro Ellipta$421$68,50878 claims
MerckJanuvia, Janumet, Janumet Xr$197$61,47154 claims
AstraZenecaFarxiga, Brilinta, Breztri Aerosphere, Symbicort$1,385$59,78987 claims
Otsuka America Pharmaceutical, Inc.Rexulti$118$47,92520 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$390$18,82120 claims
AbbVieSynthroid$2,387$4,24650 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,216 internal medicine providers in Tennessee.

Other internal medicine in Talbott

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →